Loading...
Update on pharmacotherapies for cholestatic liver disease
Cholestatic liver diseases are conditions with impaired bile formation and/or flow due to genetic, immunologic, environmental, or other causes. Unless successfully treated, this can lead to chronic liver injury and end‐stage liver disease. Primary biliary cholangitis (PBC) and primary sclerosing cho...
Na minha lista:
| Udgivet i: | Hepatol Commun |
|---|---|
| Main Authors: | , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
John Wiley and Sons Inc.
2016
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5747033/ https://ncbi.nlm.nih.gov/pubmed/29404429 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/hep4.1013 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|